Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization.

Jäger R, Purpura M, Farmer S, Cash HA, Keller D.

Probiotics Antimicrob Proteins. 2018 Dec;10(4):611-615. doi: 10.1007/s12602-017-9354-y. Review.

2.

Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro.

Jensen GS, Cash HA, Farmer S, Keller D.

J Inflamm Res. 2017 Aug 7;10:107-117. doi: 10.2147/JIR.S141660. eCollection 2017.

3.

Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer.

Morisada M, Moore EC, Hodge R, Friedman J, Cash HA, Hodge JW, Mitchell JB, Allen CT.

Oral Oncol. 2017 Aug;71:87-94. doi: 10.1016/j.oraloncology.2017.06.005. Epub 2017 Jun 10.

4.

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers.

Moore EC, Cash HA, Caruso AM, Uppaluri R, Hodge JW, Van Waes C, Allen CT.

Cancer Immunol Res. 2016 Jul;4(7):611-20. doi: 10.1158/2326-6066.CIR-15-0252. Epub 2016 Apr 13.

5.

Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.

Nyangale EP, Farmer S, Cash HA, Keller D, Chernoff D, Gibson GR.

J Nutr. 2015 Jul;145(7):1446-52. doi: 10.3945/jn.114.199802. Epub 2015 May 6.

PMID:
25948780
6.

Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ).

Hinds TD Jr, Stechschulte LA, Cash HA, Whisler D, Banerjee A, Yong W, Khuder SS, Kaw MK, Shou W, Najjar SM, Sanchez ER.

J Biol Chem. 2011 Dec 16;286(50):42911-22. doi: 10.1074/jbc.M111.311662. Epub 2011 Oct 12.

7.

Discovery of glucocorticoid receptor-beta in mice with a role in metabolism.

Hinds TD Jr, Ramakrishnan S, Cash HA, Stechschulte LA, Heinrich G, Najjar SM, Sanchez ER.

Mol Endocrinol. 2010 Sep;24(9):1715-27. doi: 10.1210/me.2009-0411. Epub 2010 Jul 21.

8.

Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.

Warrier M, Hinds TD Jr, Ledford KJ, Cash HA, Patel PR, Bowman TA, Stechschulte LA, Yong W, Shou W, Najjar SM, Sanchez ER.

Endocrinology. 2010 Jul;151(7):3225-36. doi: 10.1210/en.2009-1158. Epub 2010 Apr 28.

9.

In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.

Sorensen RU, Klinger JD, Cash HA, Chase PA, Dearborn DG.

Infect Immun. 1983 Jul;41(1):321-30.

10.

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.

Powell SH, Thompson WL, Luthe MA, Stern RC, Grossniklaus DA, Bloxham DD, Groden DL, Jacobs MR, DiScenna AO, Cash HA, Klinger JD.

J Infect Dis. 1983 May;147(5):918-32.

PMID:
6860416
11.

Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.

Cash HA, Straus DC, Bass JA.

Can J Microbiol. 1983 Apr;29(4):448-56.

PMID:
6406026
12.

Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.

Klinger JD, Cash HA, Wood RE, Miler JJ.

Infect Immun. 1983 Mar;39(3):1377-84.

13.

A rat model of chronic respiratory infection with Pseudomonas aeruginosa.

Cash HA, Woods DE, McCullough B, Johanson WG Jr, Bass JA.

Am Rev Respir Dis. 1979 Mar;119(3):453-9.

PMID:
109021

Supplemental Content

Support Center